ticker,nameOfIssuer,cusip,value,shares,allocation_percent,filingDate,reportDate,accessionNumber
2L9,BLUEPRINT MEDICINES CORP,09627Y109,82123000.0,2765080,15.475196683469166,2016-11-14,2016-09-30,0000921895-16-006168
CCXIEUR,CHEMOCENTRYX INC,16383L106,48707000.0,8064019,9.17831064210675,2016-11-14,2016-09-30,0000921895-16-006168
CYTK,CYTOKINETICS INC,23282W605,45873000.0,4997071,8.644273802233005,2016-11-14,2016-09-30,0000921895-16-006168
ARRYEUR,ARRAY BIOPHARMA INC,04269X105,43613000.0,6461186,8.21840109294766,2016-11-14,2016-09-30,0000921895-16-006168
N/A,CASCADIAN THERAPEUTICS INC,14740B101,30831000.0,18799368,5.809770575210817,2016-11-14,2016-09-30,0000921895-16-006168
N/A,FORWARD PHARMA A/S,34986J105,29145000.0,1387853,5.492061996513874,2016-11-14,2016-09-30,0000921895-16-006168
N/A,COLUCID PHARMACEUTICALS INC,19716T101,29120000.0,763300,5.48735101521647,2016-11-14,2016-09-30,0000921895-16-006168
CNCEEUR,CONCERT PHARMACEUTICALS INC,206022105,27532000.0,2723210,5.188109483205352,2016-11-14,2016-09-30,0000921895-16-006168
XENE,XENON PHARMACEUTICALS INC,98420N105,25182000.0,3108905,4.745277241249353,2016-11-14,2016-09-30,0000921895-16-006168
N/A,ONCOMED PHARMACEUTICALS INC,68234X102,20711000.0,1812005,3.9027653460215763,2016-11-14,2016-09-30,0000921895-16-006168
N/A,GLYCOMIMETICS INC,38000Q102,17348000.0,2426282,3.2690441418947565,2016-11-14,2016-09-30,0000921895-16-006168
N/A,CTI BIOPHARMA CORP,12648L106,16767000.0,44796940,3.159560936543082,2016-11-14,2016-09-30,0000921895-16-006168
N/A,TOBIRA THERAPEUTICS INC,88883P101,15873000.0,399433,2.9910962453479057,2016-11-14,2016-09-30,0000921895-16-006168
N/A,NIVALIS THERAPEUTICS INC,65481J109,13900000.0,1709673,2.6193056013567624,2016-11-14,2016-09-30,0000921895-16-006168
ARQLUSD,ARQULE INC,04269E107,13246000.0,7400128,2.4960663306166673,2016-11-14,2016-09-30,0000921895-16-006168
CTMX,CYTOMX THERAPEUTICS INC,23284F105,9280000.0,591813,1.7487162575964572,2016-11-14,2016-09-30,0000921895-16-006168
N/A,IMMUNE DESIGN CORP,45252L103,9096000.0,1200000,1.7140434352475622,2016-11-14,2016-09-30,0000921895-16-006168
N/A,GTX INC DEL,40052B108,9014000.0,11512000,1.6985914165920761,2016-11-14,2016-09-30,0000921895-16-006168
INFIQ,INFINITY PHARMACEUTICALS INC,45665G303,8033000.0,5149644,1.5137325104819335,2016-11-14,2016-09-30,0000921895-16-006168
PTGX,PROTAGONIST THERAPEUTICS INC,74366E102,7924000.0,375000,1.4931926320252509,2016-11-14,2016-09-30,0000921895-16-006168
ESPR,ESPERION THERAPEUTICS INC NE,29664W105,6840000.0,493872,1.2889244829698026,2016-11-14,2016-09-30,0000921895-16-006168
ADROEUR,ADURO BIOTECH INC,00739L101,6229000.0,501155,1.1737881000612427,2016-11-14,2016-09-30,0000921895-16-006168
SNSSEUR,SUNESIS PHARMACEUTICALS INC,867328700,3192000.0,730361,0.6014980920525745,2016-11-14,2016-09-30,0000921895-16-006168
OREXQ 2.75 12/01/20,OREXIGEN THERAPEUTICS INC,686164AB0,2650000.0,10000000,0.4993640175248505,2016-11-14,2016-09-30,0000921895-16-006168
N/A,OREXIGEN THERAPEUTICS INC,686164302,2440000.0,734976,0.45979177462665477,2016-11-14,2016-09-30,0000921895-16-006168
N/A,PAIN THERAPEUTICS INC,69562K100,2278000.0,2278552,0.4292646158194752,2016-11-14,2016-09-30,0000921895-16-006168
N/A,PIERIS PHARMACEUTICALS INC,720795103,1858000.0,1016593,0.35012013002308384,2016-11-14,2016-09-30,0000921895-16-006168
N/A,CATALYST BIOSCIENCES INC,14888D109,1048000.0,865773,0.19748433598718615,2016-11-14,2016-09-30,0000921895-16-006168
GBIM,GLOBEIMMUNE INC,37957B100,822000.0,657653,0.15489706505865172,2016-11-14,2016-09-30,0000921895-16-006168
